MIRA INFORM REPORT

 

 

Report Date :

07.01.2011

 

IDENTIFICATION DETAILS

 

Correct Name :

PHARM CARES CO.

 

 

Registered Office :

17, Byeoryang-dong, Gwacheon-si, Gyeonggi-do, Korea, Suite 348-502, Samsung-Reamian Apt. 427-802

 

 

Country :

South Korea

 

 

Date of Incorporation :

Not Available

 

 

Com. Reg. No.:

Not Available

 

 

Legal Form :

Sole Proprietorship

 

 

Line of Business :

Wholesaler of Pharmaceutical Products

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2010

 

Country Name

Previous Rating

                   (01.04.2010)                  

Current Rating

(30.06.2010)

South Korea

a1

a1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

Basic

 

Company Name

PHARM CARES CO.

(Korean Company Name : “팜케어스”)

Registered Address

17, Byeoryang-dong, Gwacheon-si, Gyeonggi-do, Korea

Building

Suite 348-502, Samsung-Reamian Apt.

Zip Code

427-802

Tel

N/A

Fax

N/A

E-mail

pharmcares@naver.com

Trading Address

Suite 348-502, Samsung-Reamian Apt., 17, Byeoryang-dong, Gwacheon-si, Gyeonggi-do, Korea

Tel

N/A

Fax

N/A

Type

Import

Industry

Wholesales of Pharmaceutical Products

  Main Business

Pharmaceutical Products

Established (mm/dd/yyyy)

N/A

Mr. Kim Hyun-Jong and other(1) own the premises of registered HQ address.

 

 

Detailed Products

 

Activity

Detailed Products (UNSPSC)

Sell

Pharmaceutical Products

Sell

Packing Materials

 

 

CEO’s

 

Name

Kim Hyun-Jong(Mobile : +82-10-6334-5582)

Title

Owner

Sex

Male

Nationality

Korean

 

 

Profiles

 

Capital (KRW)

Not Applicable to the Sole Proprietorship

Employees

1

Formation

Sole Proprietorship

Bank Details

Woori Bank

Corporate Registered No.

Not Applicable to the Sole Proprietorship

Business Registered No.

N/A. (The numbers are kept by the National Tax Service confidentially.)

Permit & Licenses

N/A

Shareholder Position

The owner has 100% shares.

Company History

N/A

 

Due to lack of the information, we contacted at +82-17-334-5582, and it has changed to +82-10-6334-5582. We interviewed with Mr. Kim Hyun-Jong, and he confirmed of the company name as PHARM CARES CO. However, he gently rejected to release their information unless he know who is about to get the information on them.

 

 

Management

 

Job Description

Title

Name

Sex

Nationality

Inauguration Date

Owner

Mr.

Kim Hyun-Jong

Male

Korean

N/A

 

 

Financials

 

The financials are not available, and the Subject Company does not have any obligations to release its financials to the public.

 

 

Financial Description

 

Authorized Capital(KRW)

Not Applicable to the Sole Proprietorship

Paid-Up Capital(KRW)

Not Applicable to the Sole Proprietorship

Total Issues Shares

Not Applicable to the Sole Proprietorship

 

 

Products, Technologies, Services Description

 

Main Products & Services

Pharmaceutical Products

 

 

Trade Partners & Competitors

 

Competitors

HIGH TECH PHARM. CO., LTD.

576-1, SEONGBON-RI, DAESO-MYEON, EUMSEONG-GUN, CHUNGCHEONGBUK-DO, KOREA

TEL:+82-43-883-0012  FAX:+82-43-883-0014

 

HANSEO CHEM CO., LTD.

2-DANJI, POSEUNG NATIONAL INDUSTRIAL COMPLEX, 1206-14, WONJEONG-RI, POSEUNG-EUP, PYEONGTAEK-SI, GYEONGGI-DO, KOREA

TEL:+82-31-682-8655  FAX:+82-31-682-8656

 

DAEBONG LS CO., LTD.

122B-9L, NAMDONG INDUSTRIAL COMPLEX, 692-8, GOJAN-DONG, NAMDONG-GU, INCHEON, KOREA

TEL:+82-32-817-8800~7  FAX:+82-32-817-8808

 

 

Sales by Region

(Activity & Markets)

 

The Subject imports from India.

 

 

Court Action

 

Not Available.

 

 

News Clipping

 

---

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.31

UK Pound

1

Rs.70.26

Euro

1

Rs.59.56

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.